FY2025 Earnings Estimate for Waters Issued By KeyCorp

Waters Co. (NYSE:WAT) – Equities researchers at KeyCorp issued their FY2025 earnings per share (EPS) estimates for Waters in a report released on Monday, March 31st. KeyCorp analyst P. Knight forecasts that the medical instruments supplier will post earnings of $12.76 per share for the year. KeyCorp currently has a “Overweight” rating and a $460.00 target price on the stock. The consensus estimate for Waters’ current full-year earnings is $12.86 per share.

Waters (NYSE:WAT) last released its quarterly earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%.

Other analysts have also recently issued research reports about the stock. JPMorgan Chase & Co. lifted their price objective on shares of Waters from $380.00 to $390.00 and gave the stock a “neutral” rating in a research note on Thursday, March 6th. UBS Group boosted their price target on Waters from $405.00 to $410.00 and gave the company a “neutral” rating in a research note on Thursday, February 13th. Sanford C. Bernstein raised Waters from a “market perform” rating to an “outperform” rating and set a $430.00 price target on the stock in a research report on Friday, January 10th. Wells Fargo & Company lifted their price objective on Waters from $415.00 to $420.00 and gave the company an “overweight” rating in a report on Thursday, February 13th. Finally, Barclays raised Waters from an “underweight” rating to an “equal weight” rating and increased their target price for the stock from $360.00 to $415.00 in a report on Monday, February 10th. Ten analysts have rated the stock with a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $401.31.

Waters Trading Down 3.6 %

Shares of Waters stock opened at $355.43 on Wednesday. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.65 and a current ratio of 0.94. The firm has a 50-day moving average of $385.54 and a 200-day moving average of $373.45. Waters has a 52-week low of $279.24 and a 52-week high of $423.56. The stock has a market cap of $21.12 billion, a PE ratio of 33.19, a PEG ratio of 3.79 and a beta of 1.00.

Hedge Funds Weigh In On Waters

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Aster Capital Management DIFC Ltd acquired a new position in shares of Waters during the fourth quarter worth $28,000. Bank of Jackson Hole Trust acquired a new position in Waters in the 4th quarter worth about $34,000. Fortitude Family Office LLC raised its position in Waters by 235.7% in the fourth quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock valued at $35,000 after purchasing an additional 66 shares during the last quarter. Steward Partners Investment Advisory LLC grew its holdings in shares of Waters by 129.3% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier’s stock worth $35,000 after purchasing an additional 53 shares during the last quarter. Finally, Murphy & Mullick Capital Management Corp acquired a new position in shares of Waters in the fourth quarter valued at approximately $42,000. Institutional investors own 94.01% of the company’s stock.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.